InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Kilcoyne Adrian, Directeur Médical. Director active across 2 companies, notably Humanigen, INC. In total, 4 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €16k. History available since 8 March 2022. The latest transaction was filed on 17 February 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Adrian Kilcoyne is the Chief Medical Officer of Humanigen, Inc. He is responsible for the company's medical strategy and research initiatives. His role is essential in ensuring regulatory compliance and guiding the development of new treatments. His expertise contributes to Humanigen, Inc.'s mission to improve patient health.